|
Volumn 32, Issue 7, 2000, Pages 2248-2249
|
Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients
a,b a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
LAMIVUDINE;
STEROID;
TACROLIMUS;
ARTICLE;
CLINICAL ARTICLE;
DRUG EFFICACY;
HEPATITIS B;
HUMAN;
HUMAN TISSUE;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RECURRENT DISEASE;
ADULT;
ANTIVIRAL AGENTS;
CADAVER;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS B;
HEPATITIS B SURFACE ANTIGENS;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS;
IMMUNOSUPPRESSIVE AGENTS;
LAMIVUDINE;
LIVER TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
RECURRENCE;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TISSUE DONORS;
|
EID: 0033670287
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)01786-3 Document Type: Article |
Times cited : (9)
|
References (13)
|